Mumbai, Jan 14 (UNI) Pharmaceutical and Biotechnology major
Wockhardt, has signed an in-licensing agreement with a Swiss firm,
If you enjoyed reading this article, you can help support our journalism by adding OHeraldo as a preferred source.
DSM Nutritional products AG, to market Bonistein, a patented product,
specially designed in the management of osteoporosis.
Wockhardt chairman H Khorakhwala said ” There is a growing
awareness of the debilitating problem of osteoporosis in india.
Bonistein, an internationally acclaimed brand, will complement and
further strengthen our existing orthopoedic portfolio. ”
” The Company will continue to offer the indian medical
practitioners break through products that will cater to the needs of
these emerging problems in an holistic manner” he added.
India has close to 61 million people reportedly suffering from
osteoporosis and nearly 50 per cent of this population are
post-menopausal women. By 2030, as per the World Health Organisation
(WHO), the population of post-menopausal women suffering from
osteoporosis will be the second highest in the world next only to
China, a company release said here today.
